SCHEDULE 13G/AFiled May 14, 8:00 PM ET

Lyell Immunopharma, Inc. SCHEDULE 13G/A

Foresite Capital Fund IV, L.P.

Summary not available

This filing does not have a generated research summary. You can still open the original filing and its exhibits.